304 related articles for article (PubMed ID: 21159209)
21. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
[TBL] [Abstract][Full Text] [Related]
22. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
Schepman KP; van der Meij EH; Smeele LE; van der Waal I
Oral Oncol; 1998 Jul; 34(4):270-5. PubMed ID: 9813722
[TBL] [Abstract][Full Text] [Related]
23. [White lesions of the oral mucosa: leukoplakia].
de Visscher JGAM; van der Meij EH
Ned Tijdschr Tandheelkd; 2023 May; 130(5):232-236. PubMed ID: 37157988
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic factors associated with malignant transformation of oral leukoplakias: a retrospective cohort study.
Jäwert F; Pettersson H; Jagefeldt E; Holmberg E; Kjeller G; Öhman J
Int J Oral Maxillofac Surg; 2021 Nov; 50(11):1422-1428. PubMed ID: 33674140
[TBL] [Abstract][Full Text] [Related]
25. Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders.
Sperandio M; Brown AL; Lock C; Morgan PR; Coupland VH; Madden PB; Warnakulasuriya S; Møller H; Odell EW
Cancer Prev Res (Phila); 2013 Aug; 6(8):822-31. PubMed ID: 23761273
[TBL] [Abstract][Full Text] [Related]
26. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia.
Kaur J; Matta A; Kak I; Srivastava G; Assi J; Leong I; Witterick I; Colgan TJ; Macmillan C; Siu KW; Walfish PG; Ralhan R
Int J Cancer; 2014 Mar; 134(6):1379-88. PubMed ID: 24122701
[TBL] [Abstract][Full Text] [Related]
27. Risk assessment of malignant transformation of oral leukoplakia in patients with previous oral squamous cell carcinoma.
Yang SW; Lee YC; Lee YS; Chang LC; Lai YR
Int J Oral Maxillofac Surg; 2022 Nov; 51(11):1394-1400. PubMed ID: 35249786
[TBL] [Abstract][Full Text] [Related]
28. Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study.
Liu W; Feng JQ; Shen XM; Wang HY; Liu Y; Zhou ZT
Cancer; 2012 Mar; 118(6):1693-700. PubMed ID: 22009787
[TBL] [Abstract][Full Text] [Related]
29. Snail and Axin2 expression predict the malignant transformation of oral leukoplakia.
Zhang X; Kim KY; Zheng Z; Kim HS; Cha IH; Yook JI
Oral Oncol; 2017 Oct; 73():48-55. PubMed ID: 28939076
[TBL] [Abstract][Full Text] [Related]
30. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma.
Lumerman H; Freedman P; Kerpel S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Mar; 79(3):321-9. PubMed ID: 7621010
[TBL] [Abstract][Full Text] [Related]
31. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
[TBL] [Abstract][Full Text] [Related]
32. Oral premalignant lesions: from a clinical perspective.
Amagasa T; Yamashiro M; Uzawa N
Int J Clin Oncol; 2011 Feb; 16(1):5-14. PubMed ID: 21225307
[TBL] [Abstract][Full Text] [Related]
33. The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia.
Ries J; Vairaktaris E; Agaimy A; Bechtold M; Gorecki P; Neukam FW; Nkenke E
Oncol Rep; 2013 Sep; 30(3):1149-56. PubMed ID: 23784518
[TBL] [Abstract][Full Text] [Related]
34. Survival study of leukoplakia malignant transformation in a region of northern Spain.
Gandara-Vila P; Perez-Sayans M; Suarez-Penaranda JM; Gallas-Torreira M; Somoza-Martin J; Reboiras-Lopez MD; Blanco-Carrion A; Garcia-Garcia A
Med Oral Patol Oral Cir Bucal; 2018 Jul; 23(4):e413-e420. PubMed ID: 29924757
[TBL] [Abstract][Full Text] [Related]
35. Malignant transformation of oral leukoplakia: a follow-up study.
Jayasooriya PR; Dayaratne K; Dissanayake UB; Warnakulasuriya S
Clin Oral Investig; 2020 Dec; 24(12):4563-4569. PubMed ID: 32436158
[TBL] [Abstract][Full Text] [Related]
36. Clinical, histopathological characteristics and malignant transformation of proliferative verrucous leukoplakia with 36 patients: a retrospective longitudinal study.
Zhang C; Lan Q; Wei P; Gao Y; Zhang J; Hua H
BMC Oral Health; 2024 May; 24(1):639. PubMed ID: 38816724
[TBL] [Abstract][Full Text] [Related]
37. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia.
Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW
J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153
[TBL] [Abstract][Full Text] [Related]
38. Expression of p16 in oral cancer and premalignant lesions.
Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
[TBL] [Abstract][Full Text] [Related]
39. [Proliferative verrucous leukoplakia. Report of five cases].
Reichart PA; Philipsen HP
Mund Kiefer Gesichtschir; 2003 May; 7(3):164-70. PubMed ID: 12764683
[TBL] [Abstract][Full Text] [Related]
40. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital.
Hsue SS; Wang WC; Chen CH; Lin CC; Chen YK; Lin LM
J Oral Pathol Med; 2007 Jan; 36(1):25-9. PubMed ID: 17181738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]